Interestingly, SAA has been recently identified by serum proteomic technologies as a potentially useful biomarker for human tumors, including renal cell carcinoma [10], lung cancer [11], melanoma [12], endometrial cancer [13] and nasopharyngeal cancer [14]. This evidence concerns the gene SAA1 and melanoma.